|
|
General
|
| |
Clinical Use:
|
Patients treated with bismuth compounds may have enhanced absorption with high levels in blood and urine. Encephalopathy may develop but is usually reversible when treatment ceases. Rapid renal clearance maintains low circulating levels so clinical and biochemical levels are more likely with renal insufficiency.
Used therapeutically in treatment of gastric and duodenal ulcers. |
| |
Availability:
|
Not routinely available. |
| |
Aliases/Synonyms:
| Bi, |
| |
Code:
|
BI |
| |
Handling Instructions (to laboratory):
|
Send sample chilled. |
| |
Hyperlink:
|
|
| |
Reference Interval:
|
Whole Blood: 0 - 4 nmol/L
(Therapeutic Range < 250 nmol/L)
|
Collection Requirements
|
| |
Container:
|
EDTA (LAVENDER), |
| |
Sample Type:
|
See container |
| |
Minimum Collection Volume:
|
4mL |
| |
Collection Instructions:
|
|
Processing Requirements
|
| |
Alternate Containers:
|
|
| |
Processing Instructions:
|
Do not centrifuge sample. |
| |
Minimum Assay Volume:
|
0.5mL |
| |
Stability:
|
|
| |
Transport Instructions (to testing laboratory):
|
Send sample chilled.
Requests should be reviewed by Duty Biochemist prior to transport. |
Testing Locations
|
| |
Performed at:
|
|
Section
|
Department
|
Site
|
Contact Phone
|
| - |
Laboratory |
SSWPS-Royal Prince Alfred Hospital |
(02) 9515 8279 |
|
Last Updated : 23-11-2023 13:38 |